Analysis of ERG11 gene mutation in Candida albicans

Abstract

Abstract: Objective To study the relationship between fluconazole (FCZ)-resistance of Candida albicans and the mutation of ERG11 gene encoding FCZ-targeted enzyme. Method Three strains of FCZ-susceptible and 10 FCZ-resistent C. albicans were isolated from the urethra, vagina, oropharynx, respiratory tract, prostate secretion and blood samples. ERG11 gene was amplified by PCR using C. albicans genomic DNA extracts as the templates and the DNA sequences of the PCR products were determined and compared using BLAST and Clustal-W softwares. Results The comparison of ERG11 gene sequences identified mutations at 21 sites in 13 strains, including 17 same-sense and 4 missense mutations. Base substitutions at the sites of 348 bp and 383 bp resulting in D116E and K128T conversion may take place in both drug-resistant and drug-susceptible strains. The point mutation at the site of 1309 bp of FCZ-resistant strain may cause V437I change, and the base inversion at 1320 bp may give rise to A/C heterozygosity mutant of ERG11 gene, probably resulting in N440K conversion. Conclusion FCZ-resistance of C. albicans may be associated with point mutations of V437I and N440K in ERG11 gene, but not with the point mutations of D166E and K128T.

CLC Number:

R949.32

WANG Ying-bin^1,3, WANG Hong², GUO Hui-yu³, ZHAO Yong-zhong², LUO Shen-qiu². Analysis of ERG11 gene mutation in Candida albicans[J]. Journal of Southern Medical University, 2005, 25(11): 1390-1393.

References

[1] Loeffler J, Hagmeyer L, Hebart H, et al. Rapid detection of point mutations by fluorescence resonance energy transfer and probe melting curves in Candida species[J]. Clin Chem, 2000, 46(5):631-5.
[2] White TC, Holleman S, Dy F, et al. Resistance mechanisms in clinical isolates of Candida albicans[J]. Antimicrob Agents Chemother,2002, 46(6): 1704-13.
[3] 王应斌,王宏,郭辉玉,等.应用M13引物PCR指纹法分析假丝酵母菌氟康唑耐药性[J].第一军医大学学报,2003,23(12):1303-6.Wang YB, Wang H, Guo HY, et al. Fluconazole resistance in Candida albicans assayed by PCR fingerprinting with M13 prime.[J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao, 2003, 23(12): 1303-6.
[4] Peters S, Koschinsky S, Schwieger F, et al. Succession of microbial communities during hot composting as detected by PCR-singlestrand-conformation polymorphism-based genetic profiles of small-subunit rRNA genes[J]. Appl Environ Microbiol, 2000, 66(3): 930-6.
[5] Perea S, Lopez-Ribot JL, Kirkpatrick WR, et al. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients[J].Antimicrob Agents Chemother, 2001, 45(10): 2676-84.
[6] AoyamaY, KudoM, AsaiK, et al. Emergence of fluconazoleresistant sterol 14-demethylase P450 (CYPS1) in Candida albicans is a model demonstrating the diversification mechanism of P450[J].Arch Biochem Biophys, 2000, 379(1): 170-1.
[7] Walsh TJ, Francesconi A, Kasai M, et al. PCR and single-strand conformational polymorphism for recognition of medically important opportunistic fungi[J]. J Clin Microbiol, 1995, 33(12): 3216-20.
[8] Sanglard D, Ischer F, Koymans L, et al. Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A 1)from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents[J]. Antimicrob Agents Chemother,1998, 42(2): 241-53.
[9] 龙丰,张永信,兰和魁,等.耐氟康唑白色念珠菌ERG11的基因突变[J].中华传染病杂志,2002,20(4):211-4.Long F, Zhang YX, Lan HK, etal. The point mutation of cytochrome P-450 lanosterol 14-α demethylase ERG11 gene in fluconazole resistant Candida albicans[J]. Chin J Infect Dis, 2002,20(4): 211-4.
[10] Song JL, Harry JB, Eastman RT, et al. The Candida albicans lanosterol 14-alpha-demethylase (ERG11) gene promoter is maximally induced after prolonged growth with antifungal drugs[J].Antimicrob Agents Chemother, 2004, 48(4): 1136-44.
[11] Marr KA, Lyons CN, Rustad TR, et al. Rapid, transient fluconazole resistance in Candida albicans is associated with increased mRNA levels of CDR[J]. Antimicrob Agents Chemother, 1998, 42(10):2584-9.
[12] Barker KS, Crisp S, Wiederhold N, et al. Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans[J]. J Antimicrob Chemother, 2004, 54(2): 376-85.
[13] Karababa M, Coste AT, Rognon B, et al. Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs inducing multidrug transporters[J]. Antimicrob Agents Chemother, 2004, 48(8): 3064-79.